ERK5 Interacts with Mitochondrial Glutaminase and Regulates Its Expression
Yolanda María Guillén-Pérez(Consejo Superior de Investigaciones Científicas), Azucena Esparı́s-Ogando(Instituto de Investigación Biomédica de Salamanca)
Cited by 2
Related Papers
Therapeutic potential of ERK5 targeting in triple negative breast cancer
|Oncotarget|2014|48
Clinical, genetic and pharmacological data support targeting the MEK5/ERK5 module in lung cancer
|npj Precision Oncology|2021|31
The WNK1–ERK5 route plays a pathophysiological role in ovarian cancer and limits therapeutic efficacy of trametinib
|Clinical and Translational Medicine|2023|11